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Preeclampsia and maladaptation to pregnancy: A role for atrial pregnancy-related syndromes that develop in women
natriuretic peptide? with a pre-existent vascular, metabolic, or clotting disor-
Background. The majority of women with a history of pre- der [1, 2]. The pathogenesis of these syndromes mayeclampsia have either an underlying thrombophilic disorder or
begin as early as at the time of implantation, as indicateda vascular disorder. In this study, we tested the hypothesis that
by poor trophoblast invasion and abnormal hemody-only the latter condition predisposes for abnormal hemody-
namic adaptation to pregnancy. namic adaptation with a common endpoint of endothelial
Methods. Thirty-seven formerly preeclamptic subjects were dysfunction [3, 4]. It follows that most of the pathogenetic
subdivided into a hypertensive (HYPERT, N  10), a normo- cascade evolves subclinically over a period of at leasttensive thrombophilic (THROMB, N  13) and a normoten-
five months. It is obscure whether the heterogeneity insive nonthrombophilic subgroup (NONTHROMB, N  14).
In these women and in 10 normal parous controls, the following predisposing conditions as mentioned previously gives rise
variables were measured at least five-months postpartum at to a similar cascade of events in the period between defec-
day 5 (2) of the menstrual cycle and again at five- and seven- tive implantation and the appearance of clinical symptoms
weeks amenorrhea in the next pregnancy: mean arterial pres-
caused by endothelial dysfunction. Most early pregnancysure, heart rate, cardiac output, central cardiovascular dimen-
changes in maternal hemodynamics are compensationssions, plasma volume, glomerular filtration rate, effective renal
plasma flow, 17- estradiol, progesterone, the hormones of the triggered by systemic vasorelaxation [5–7]. These changes
renin-angiotensin-aldosterone (RAAS) axis, catecholamines include the rise in cardiac output, renin-angiotensin-
and -atrial natriuretic peptide. aldosterone system (RAAS) activity, and plasma volume.Results. The early pregnancy rise in cardiac output, renal
Theoretically, formerly preeclamptic women with a throm-variables, RAAS activity, and plasma volume was comparable
bophilic phenotype and normal cardiovascular functionin all groups. However, the HYPERT and NONTHROMB
subgroups differed from controls by a lower plasma volume can be expected to have a normal early pregnancy hemo-
in the prepregnant state. In addition, only the women in these dynamic compensatory response. Alternatively, formerly
two subgroups responded to pregnancy by a rise in circulating preeclamptic women with hypertension or “latent” hy--atrial natriuretic peptide. In addition, at seven weeks, in
pertension are probably more likely to show abnormalthe subjects belonging to the HYPERT and NONTHROMB
early pregnancy changes [8]. If the pathogenetic cascadesubgroups, plasma volume was the lowest and correlated in-
versely with the concomitant circulating level of -atrial natri- between these two most important risk groups is indeed
uretic peptide. different in early pregnancy, it not only explains the
Conclusion. The hemodynamic adaptation to pregnancy in
modest yield of various recently reported preventionthe HYPERT and NONTHROMB subgroups differs from that
strategies executed in unselected groups of women atin THROMB and controls by an early pregnancy rise in -atrial
natriuretic peptide. As a consequence, the early pregnancy risk for preeclampsia [9], but it also increases our under-
plasma volume expansion in the NONTHROMB and HYP- standing of the pathogenesis of preeclampsia and may
ERT subgroups is less than in normal parous controls. provide valuable information about possible preventive
measures in selected risk groups.
This study tested the hypothesis that the adaptation
In the last decade, evidence has accumulated support- to pregnancy in women with a history of preeclampsia
ing the concept that preeclampsia and HELLP syndrome depends on the predisposing condition. That is, the adap-
(Hemolysis, Elevated Liver enzymes, Low Platelets) are tation to pregnancy differs between women likely to have
a pre-existent cardiovascular disorder and women with
a thrombophilic phenotype. To this end, we divided aKey words: hypertension, menstrual cycle, cardiac output, hemody-
namics, volume homeostasis, plasma volume, 17- estradiol. group of formerly preeclamptic women into subgroups
with or without hypertension. The normotensive group 2001 by the International Society of Nephrology
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was further subdivided into females with or without formed consent. The hospital’s medical ethical commit-
tee approved the study.thrombophilia. These three groups were compared with
The methodology of the measurements and calcula-a group of normal parous controls.
tions on the thrombophilic screening and hemodynamic
function were described previously [8].
METHODS
Thrombophilic screening
Selection and patient characteristics
In short, anticardiolipin antibodies were determined
Sixty-five formerly preeclamptic women who experi- spectrophotometrically by enzyme-linked immunosorbent
enced a clinically severe preeclampsia and who were assay (ELISA). Lupus anticoagulant was determined by
planning another pregnancy were eligible for inclusion mixing 1:1 patient and pooled normal plasma after finding
in the study. All consented to the study protocol. Two a prolonged partial thromboplastin time. Subsequently,
formerly preeclamptic women conceived prior to the first thromboplastin dilution test was performed by measur-
measurement session. Therefore, sixty-three formerly ing the prothrombin time with progressively diluted
preeclamptic, nondiabetic women and 15 normal parous thromboplastin. Lupus anticoagulant was considered to
controls were enrolled in this study. Data acquisition be present when all assays were positive. The antiphospho-
lipid syndrome was defined as the condition where anti-was initiated at least five-months postpartum. Inclusion
cardiolipin antibodies, when higher than 10 Ig antiphos-for further analysis required a pregnancy occurring
pholipid antibodies (GPL) and 6 Ig antiphospholipidwithin one year after the prepregnant measurement ses-
antibodies (MPL), respectively, could be detected in pe-sion. Furthermore, only ongoing singleton pregnancies
ripheral blood in women with a history of preeclampsia/(gestational age 16 weeks) were included. As a conse-
HELLP syndrome. Coagulation tests were performedquence, from the group of 63 formerly preeclamptics
after a venous puncture. Plasma samples were stored atand 15 controls having completed the nonpregnant mea-
80C prior to assay. Protein C activity was determinedsurement sessions, only 37 formerly preeclamptic women
with Coamate protein C (Chromogenix, Mo¨lndal, Swe-and 10 controls could be included for final analysis. All
den). Total protein S antigen and free protein S weresubjects were Caucasian, and the ones who smoked (N
measured by an ELISA (Dako, Glostrup, Denmark).
9) refrained from smoking during pregnancy. Formerly Activated protein C resistance was quantified by a
preeclamptic women were recruited from the outpatient chromogenic-activated protein C-resistance assay. Anti-
clinic at the time of postpartum follow-up. Controls were thrombin activity was assayed with chromogenic sub-
recruited by advertisement. Preeclampsia and (gesta- strate S-2765 (Chromogenix). A methionine-loading test
tional) hypertension were defined according to the crite- was used to diagnose hyperhomocysteinemia. Homocys-
ria of the Report of the National High Blood Pressure teine was measured by high-performance liquid chroma-
Education Program Working Group on High Blood tography with fluorescence detection. Individuals were
Pressure in Pregnancy [10]. All experiments were pre- considered to have hyperhomocysteinemia when fasting
ceded by one week of standardized sodium intake (100 and/or postload plasma homocysteine levels were more
than two standard deviations higher than the mean ofmmol sodium per day), representing the mean sodium
the laboratory control group.intake in our population. To this end, all participants
consulted the hospital’s dietitian, prior to study. Compli-
Measurement of blood pressure andance with the diet was assessed by measuring each wom-
renal hemodynamics
an’s 24-hour sodium output on the day before the experi-
In the midfollicular phase (day 5 2) of the menstrualment. None of the participants used vitamin supplements
period and at five and seven weeks in the subsequentor any other medication in the two weeks prior to mea-
pregnancy, measurements were performed under stan-surement. Women on antihypertensive drugs (N  2,
dardized environmental conditions in a temperature-labetalol) discontinued this medication at least one week
controlled room (25 to 26C) and with as minimal exter-
prior to the study session but not in early pregnancy. On nal disturbances as possible. Participants did not drink
separate days and after an overnight fast, all participants caffeine- or alcohol-containing beverages and refrained
were tested for thrombophilia and hemodynamic func- from smoking and eating for at least 10 hours before the
tion. Thrombophilia was defined as the condition charac- experiment. The measurement session started at 8 a.m.
terized by the presence of at least one clotting disorder with the insertion of a 20-gauge catheter into a vein
known to be associated with an increased risk to develop of the right forearm to enable determination of renal
venous thromboembolism. After the measurement ses- function as detailed below [8]. A second catheter was
sions, formerly preeclamptic women were evaluated as inserted into a vein of the contralateral forearm for sam-
pling of blood. Throughout each measurement session,illustrated in Figure 1. All participants gave written in-
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Fig. 1. Management and subdivision of formerly preeclamptic participants.
subjects were in supine position on a comfortable bed. At least two hours after the initiation of the PAH/
inulin infusion, three blood samples were taken for deter-Mean arterial blood pressure (MAP) and heart rate (HR)
were recorded repeatedly at two-minute intervals by a mination of inulin and PAH. In addition, blood was
collected for assay of active plasma renin concentration,semiautomatic oscillometric device (Dinamap Vital Signs
Monitor 1846; Critikon, Tampa, FL, USA) throughout angiotensin II, aldosterone, -atrial natriuretic peptide,
17- estradiol, progesterone, and catecholamines. Activethe measurement session. Effective renal plasma flow
(ERPF) and glomerular filtration rate (GFR) were mea- plasma renin concentration was determined by an immu-
noradiometric assay technique (Nichols Institute Diag-sured by continuous infusion of para-aminohippurate
(PAH) sodium (MSD, West Point, PA, USA) and inulin nostics, Wychen, The Netherlands). Angiotensin II was
assayed by radioimmunoassay (RIA) following Phenyl(Inutest, Laevosan Gesellschaft, Linz, Austria), respec-
tively. PAH and inulin were measured spectrophotomet- column extraction (Amersham Int., Amersham, UK).
Aldosterone was assessed by solid-phase protein bindingrically. Renal hemodynamics were corrected for body
surface area (BSA) and expressed in mL · min1 · 1.73 radioimmunoassay (RIA; Diagnostic Products Corpora-
tion, Los Angeles, CA, USA). In our laboratory, by them2. Effective renal blood flow (ERBF) was obtained
by dividing the effective renal plasma flow by (1hemato- methods employed, the tests did not cross-react with
progesterone. -Atrial natriuretic peptide was analyzedcrit). Renal vascular resistance (RVR, dyne · s · cm5 ·
1.732) was obtained by dividing mean arterial blood by RIA (Nichols Institute Diagnostics, Wychen, The
Netherlands). Norepinephrine, epinephrine, and dopa-pressure by the effective renal blood flow. The ratio of
glomerular filtration rate and effective renal plasma flow mine were assessed by chromatograph after liquid–liquid
extraction and derivatization with a selective fluorescentwas taken to obtain the filtration fraction (FF).
Spaanderman et al: Hemodynamic maladaptation to pregnancy1400
agent. Finally, serum 17--estradiol and progesterone dimensional echocardiography. Finally, we determined
the ultrasonic diameter of the inferior vena cava [7].were determined with a commercially available solid-
phase RIA kit (DPC, Los Angeles, CA, USA). Samples
Statistical analysiswere collected on ice and centrifuged at 4C for ten
Data are presented as means  SD unless otherwiseminutes at 1500  g immediately after sampling. All
stated. Differences between groups were tested by analy-samples were stored deep-frozen (80C) prior to assay.
sis of variance (ANOVA). Differences within groupsUrinary sodium concentration was measured by standard
between the follicular phase and other measurement ses-chemical procedures in a urine sample collected over
sions were tested by Wilcoxon matched-pairs signed-the 24 hours preceding the measurement session.
ranks test, both tests with Bonferroni correction. Correla-Venous compliance, representing venous visco-elastic
tion, when calculated, between concomitantly measuredproperties, was defined as the plethysmographically de-
potentially related variables was tested by Spearman’stermined slope of the relationship of intravenous vol-
rank correlation analysis. The minimum detectableume- and pressure changes (Periflow, JSI, Beerse, Bel-
change in the paired variables studied between consecu-gium) [11, 12]. The measurement procedure has been
tive observations was calculated for the control groupdetailed previously and has a coefficient of variation of
(N 10,  0.05,  0.10), assuming a normal distribu-11.4% [11].
tion. The obtained values were 5% for mean arterial
pressure, 10% for HR, 8% for stroke volume, 15% forMeasurement of plasma volume
CO, 15% for TPVR, 9% for plasma volume, 12% forSince two of the three measurements took place in
glomerular filtration rate (GFR), 16% for ERPF, 15%early pregnancy, plasma volume was determined with
for ERBF, 18% for RVR, and 38% for atrial natriureticthe dextran-70 indicator dilution method and was ex-
peptide (ANP). Similarly, the minimum detectable dif-pressed in mL per kilogram (kg) lean body mass (LBM)
ference in these variables was calculated between the[13]. Plasma volume was obtained by dividing the total
control group and the subgroups (N  10,   0.05,  injected dextran-70 by the virtual volume-specific dex-
0.10), also assuming a normal distribution of the data.tran-70 concentration at time zero. The latter was ob-
This led to the following percentages: 19% for MAP,tained by extrapolation using the dextran-70 concentra-
22% for HR, 12% for stroke volume, 12% for CO, 19%tion determined at 10, 20, and 30 minutes after bolus
for TPVR, 10% for plasma volume, 8% for GFR, 20%injection [8, 13].
for ERPF, 21% for ERBF, 27% for RVR, and 49% forEchocardiography to assess cardiac function was per-
ANP. In all analyses, a P value of less than 0.05 wasformed in semi-left lateral position, after completion of
considered statistically significant.the plasma volume measurement and after five minutes
of rest, using a cross-sectional, phased array echocardio-
graphic Doppler system (Hewlett-Packard Sonos 2000 RESULTS
and 2500) [8]. Cardiac output (CO; L · min1) was calcu- Among the 37 formerly preeclamptic patients, 10 sub-
lated by multiplying the strike volume (mL) and heart jects had hypertension and were assigned to the HYP-
rate (HR; beats per minute). In this formula, the HR ERT subgroup. Among these hypertensive subjects, three
was obtained by taking the reciprocal of the mean of were found to have a thrombophilic disorder as well, all
five consecutive R-R intervals on the electrocardiogram in conjunction with hyperhomocysteinemia (30%). Of the
(ECG). Stroke volume was calculated by multiplying the remaining 27 normotensive formerly preeclamptic sub-
aortic velocity integral and the aortic area. Aortic flow jects, 13 had one (N 12) or more (N 1) thrombophilic
was measured across the aortic valves from an apical disorder(s), and were assigned to the THROMB sub-
approach. The average area under the aortic velocity group. The other 14 had neither hypertension nor throm-
curve (aortic velocity integral) of five consecutive ejec- bophilia and comprised the NONTHROMB subgroup.
tions was used to calculate stroke volume. Aortic valve Women not included in the final analysis as a result
diameter necessary for the calculation of the aortic area of early fetal loss at a gestational age 	16 weeks only
was measured offline at the orifice during systole using occurred in the formerly preeclamptic subgroups: three
M-mode. Cardiac index (CI; L · min1 · m2) was calcu- women in the THROMB subgroup (1 in conjunction
lated by dividing cardiac output by body surface area. with hyperhomocysteinemia, 2 with antiphospholipid an-
Total peripheral vascular resistance (TPVR; dyne · s · tibodies), one women in the HYPERT subgroup (twice
cm5) was calculated by dividing mean arterial blood a miscarriage in one year in conjunction with hyperho-
pressure by cardiac output. The value used for the MAP mocysteinemia), and two participants in the NON-
was obtained during the cardiac output measurement THROMB subgroup. The demographic characteristics
and was calculated as the mean of three consecutive and prior pregnancy data of all participants are listed in
Table 1. The three subgroups of formerly preeclampticrecordings. Left atrial diameter was measured by two-
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Table 1. Demographic (follicular phase) and prior pregnancy data from the 3 subgroups of formerly preeclamptic
women and the group of normal parous controls
Formerly preeclamptic
Controls THROMB NONTHROMB HYPERT
(N  10) (N  13) (N  14) (N  10)
Age years 312 294 293 334
Height cm 1684 1685 1686 1655
Body mass index kg ·m-2 222 223 276 267
Parity 1 (1–2) 1 (1–3) 1 (1–2) 1 (1–4)
Percentage primiparous 70 69 86 70
Mean arterial pressure mm Hg 796 826 847 1049 ↑ab
Natriuresis mmol · /24 h1 11525 9432 8933 9922
Gestational age preeclampsia weeks — 285 285 253
Gestational age at delivery weeks 392 315 ↓ 294 ↓ 274 ↓
Birth weight g 3237405 1547964 ↓ 1139870 ↓ 708456 ↓
Birth weight centile 50 (10–70) 18 (5–65) 5 (1–50) ↓ 5 (1–40) ↓
Arrow indicates higher (↑) or lower (↓) than the one in the control group (P 	 0.05). In the comparisons between the formerly preeclamptic subgroups,
a indicates a difference relative to the THROMB subgroup, whereas b indicates a difference relative to the NONTHROMB subgroup (P 	 0.05). All data are
expressed in means and SD unless ending by parentheses indicating median and range.
subjects and the controls were comparable with respect only increased in the HYPERT and control groups. At
seven weeks, venous compliance was lower in the NON-to age, height, body mass index, parity, percentage pri-
miparous women, and urinary sodium output. Obviously, THROMB subgroup as compared with controls. Except
for an increase in left atrial diameter in the NON-mean arterial blood pressure was higher in the HYPERT
subgroup as compared with controls and the two normo- THROMB subgroup at seven-weeks gestational age,
none of the central cardiovascular dimensions differedtensive formerly preeclamptic subgroups. With respect
to the prior pregnancy, formerly preeclamptic women between groups or had changed consistently with preg-
nancy in the various groups.not only gave birth at an earlier gestation, but also to
neonates with a lower birth weight and corresponding The renal hemodynamic data are listed in Table 3.
Baseline renal data in THROMB, NONTHROMB, andpercentile (the latter not in THROMB) as compared
with controls. controls were comparable. In contrast, the HYPERT
subgroup differed from controls by a lower ERPF andAmong the 37 formerly preeclamptic participants,
43% (16 out of 37) had at least one thrombophilic disor- a higher RVR. In early pregnancy, GFR, effective renal
plasma, and blood flow had increased, while RVR andder. In the subjects allocated to the THROMB subgroup,
the antiphospholipid syndrome (5 out of 13, 38%) and filtration fraction (all groups except NONTHROMB)
had decreased. Throughout the measurement period,protein S deficiency (4 out of 13, 31%) were most common,
followed by hyperhomocysteinemia (2 out of 13, 15%), RVR was consistently higher in the HYPERT subgroup
as compared with the control group.activated protein C (APC) resistance (2 out of 13, 15%),
and protein C deficiency (1 out of 13, 8%). All formerly The endocrine data are listed in Table 4. The baseline
values for the volume-regulatory hormones, catechola-preeclamptic women who were diagnosed as having the
antiphospholipid syndrome were IgG serotypes. We did mines, and sex steroids were comparable in the four
groups. All groups responded to pregnancy with a similarnot identify women with antithrombin deficiency.
The data regarding systemic hemodynamics are listed rise in RAAS activity and sex steroids. Only in HYPERT
and NONTHROMB subjects were these changes accom-in Table 2. Data collected during the follicular phase
were defined as “baseline.” Baseline systemic hemody- panied by a rise in -ANP. In these latter two groups,
the norepinephrine level in the seventh week of gestationnamics in the THROMB subgroup did not differ from
those in the control group. On the other hand, in the was lower than that in the follicular phase, while in con-
trols and THROMB women, the opposite had occurred.HYPERT subgroup, baseline cardiac output was higher
and baseline plasma volume lower than in the control Changes in epinephrine and dopamine were inconsistent.
The change in-ANP in early pregnancy not only corre-group, the latter also observed among the NON-
THROMB participants. Baseline cardiovascular dimen- lated with various changes in hemodynamic and renal
adaptation, they were also correlated with clinical phenom-sions and venous compliance did not differ between
groups. In early pregnancy, all groups responded with a ena in the prior pregnancy. We noticed that the larger
the fall in -ANP in early pregnancy, the greater wererise in stroke volume, CO, CI and plasma volume, and
a fall in TPVR and MAP. Heart rate had increased in the concomitant rises in ERPF (r  0.32, P 	 0.05),
and HR (r  0.32, P 	 0.05), but also the higher wereall groups except HYPERT. Venous compliance had
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Table 2. Hemodynamic and vascular data obtained in the follicular phase (FP) of the menstrual period (MP) and at
5 and 7 weeks amenorrhea (AM5 and AM7)
Formerly preeclamptic
Controls THROMB NONTHROMB HYPERT
MP (N  10) (N  13) (N  14) (N  10)
Mean arterial pressure mm Hg FP 796 826 847 1049abc ↑
AM5 747c 786c 816c 937abc ↑
AM7 7410c 797c 797c 947abc ↑
Heart rate bpm FP 609 607 637 6911
AM5 687c 686c 707c 739
AM7 689c 647c 676c 738
Stroke volume ml ·beat1 FP 716 7611 7710 769
AM5 799c 7911c 8111c 8111
AM7 777c 8313c 8311c 8614c
Cardiac output L·min1 FP 4.80.4 5.20.4 5.30.7 5.80.5 ↑
AM5 5.60.7c 5.70.7c 6.30.9c 6.10.6c
AM7 5.70.6c 5.70.6c 6.20.9c 6.51.0c
Cardiac index L·min-1 ·m2 FP 2.80.3 3.00.3 2.90.4 3.30.5
AM5 3.30.4c 3.40.3c 3.30.4c 3.50.4c
AM7 3.30.3c 3.40.4c 3.30.3c 3.70.5c
Total peripheral vascular FP 1.40.2 1.30.2 1.30.2 1.50.2
resistance (103) dyne · s · cm5 AM5 1.10.1c 1.10.2c 1.10.1c 1.30.2c
AM7 1.10.1c 1.10.2c 1.10.2c 1.20.2c
Venous compliance FP 5.80.9 5.91.0 4.71.3 5.21.4
ml ·100 ml1 ·mm Hg1 AM5 5.51.0 5.61.4 4.71.6 5.60.8
AM7 6.71.0c 5.71.7 4.51.0 ↓ 6.01.1c
Plasma volume ml ·kgLBM1 FP 604 554 505 ↓ 506 ↓
AM5 637c 575c 496 ↓ 535c ↓
AM7 717c 676c 558ac ↓ 548c ↓
Arrow indicates higher (↑) or lower (↓) than the one in the control group in the corresponding phase (P 	 0.05). In the comparisons between the formerly
preeclamptic subgroups, a indicates a difference relative to the THROMB subgroup, whereas b indicates a difference relative to the NONTHROMB subgroup (P 	
0.05). c Indicates the value in a particular subgroup to be different from that in the follicular phase (P 	 0.05).
Table 3. Renal hemodynamics obtained in the follicular phase (FP) of the menstrual period (MP) and
at 5 and 7 weeks amenorrhea (AM5 and AM7)
Formerly preeclamptic
Controls THROMB NONTHROMB HYPERT
MP (N  10) (N  13) (N  14) (N  10)
Glomerular filtration rate FP 1247 11520 11111 11323
ml ·min1 · 1.73 m2 AM5 14511c 13724c 1307c 13621c
AM7 15714c 15627c 14111c 14628c
Effective renal plasma flow FP 56378 502107 47470 42192 ↓
ml ·min1 · 1.73 m2 AM5 75872c 676131c 645113c 651154c
AM7 79792c 777169c 665113c 671125c ↓
Effective renal blood flow FP 878127 796190 753110 691157 ↓
ml ·min1 · 1.73 m2 AM5 1160120c 1035230c 1013192c 1026251c
AM7 1217162c 1167256a 1028170c 1033190c
Renal vascular resistance FP 7.11.3 8.72.3 8.91.8 12.53.6ab ↑
(103) dyne · s · cm5 · 1.73 m2 AM5 5.00.7c 6.11.2c 6.41.2c 7.72.4c ↑
AM7 4.80.6c 5.41.3c 6.11.1c 7.21.5ac ↑
Filtration fraction FP 0.220.02 0.230.03 0.240.03 0.270.04a ↑
GFR·ERPF1 AM5 0.190.02c 0.210.03 0.210.04 0.210.04c
AM7 0.200.03c 0.200.02c 0.220.03 0.220.04c
Sodium excretion FP 11525 9432 8933 9922
mmol ·24 h1 AM5 13449 10440 10857 11642
AM7 15777c 9534 11749 9923
Arrow indicates higher (↑) or lower (↓) than the one in the control group in the corresponding phase (P 	 0.05). In the comparisons between the formerly
preeclamptic subgroups, a indicates a difference relative to the THROMB subgroup, whereas b indicates a difference relative to the NONTHROMB subgroup (P 	
0.05). c Indicates the value in a particular subgroup to be different from that in the follicular phase (P 	 0.05).
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Table 4. Endocrine variables as determined in the follicular phase (FP) of the menstrual period (MP) and
at 5 and 7 weeks amenorrhea (AM5 and AM7)
Formerly preeclamptic
Controls THROMB NONTHROMB HYPERT
MP (N  10) (N  13) (N  14) (N  10)
Active plasma renin FP 14.23.9 14.16.9 16.78.6 17.08.6
concentration mU·L1 AM5 41.813.0 39.810.2 51.413.4 40.119.0
AM7 40.712.4 37.911.2 41.913.4 34.814.0
Angiotensin II pmol ·L1 FP 8.92.0 9.83.2 10.62.5 12.84.1
AM5 11.23.2 15.99.1 15.95.4 13.07.7
AM7 13.03.9 14.36.3 18.47.1 17.810.6
Aldosterone nmol ·L1 FP 7516 8222 10639 10843
AM5 258165 26583 288118 187149
AM7 20775 223105 236108 20673
-atrial natriuretic peptide FP 8529 10541 10450 10942
ng ·L1 AM5 7918 8332 14244 13668
AM7 8020 10329 15573 168119
Norepinephrine nmol ·L1 FP 0.710.30 0.800.34 0.760.26 1.100.36
AM5 0.910.25 1.230.46 0.980.37 1.070.37
AM7 0.960.40 0.970.38 0.640.18 0.700.19
17-Estradiol nmol ·L1 FP 0.120.09 0.110.04 0.170.08 0.140.05
AM5 0.860.62 1.020.54 1.150.65 0.990.32
AM7 1.810.87 2.210.79 2.380.86 2.111.16
Progesterone nmol · .L1 FP 1.30.5 2.01.0 2.00.7 1.40.7
AM5 48.012.5 65.117.0 51.025.9 55.733.4
AM7 54.08.4 59.220.7 63.225.2 60.027.6
Arrow indicates higher (↑) or lower (↓) than the one in the control group in the corresponding phase (P 	 0.05).
plasma volume (r0.35, P	 0.05), venous compliance condition that can be provoked by excessive exposure
(r0.33, P	 0.05), renal hemodynamics in the seventh to biochemical (that is, thrombophilia, diabetes mellitus,
week of pregnancy (ERPF, r  0.42, P 	 0.01; ERBF, and hypercholesterolemia) and/or mechanical stressors
r  0.36, P 	 0.05; GFR, r  0.31, P 	 0.05) and (that is, hypertension and renovascular disease) [14].
prior birth-weight percentile (r  0.43, P 	 0.01) and Therefore, it is plausible that preeclampsia is a disease
gestational age at delivery (r  0.32, P 	 0.05). In addi- state superimposed upon a pre-existing disorder, with
tion, among the THROMB subgroup, the fall in -ANP “endothelial decompensation” representing the common
correlated with a higher prior birth-weight percentile (r endpoint of different pathophysiologic pathways. With
0.66, P 	 0.05), gestational age at the establishment this concept as a starting point, we subdivided our group
of preeclampsia (r  0.67, P 	 0.01) and gestational of formerly preeclamptic subjects into a HYPERT and
age of delivery (r  0.55, P 	 0.05). Furthermore, at
normotensive subgroup, which was further subdividedseven weeks of pregnancy, the circulating level of -ANP
into a group of normotensive formerly preeclampticcorrelated with the seven-week plasma volume measure-
women either with or without thrombophilia (THROMBment (r0.49, P	 0.001; Fig. 2A), renal hemodynam-
and NONTHROMB, respectively). Since preeclampsiaics (ERPF, r  0.49; Fig. 2B; P 	 0.001; ERBF, r 
often is preceded by early pregnancy hemodynamic and0.40, P 	 0.01; GFR, r  0.40, P 	 0.01), TPVR
renal maladaptation as compared with uncomplicated(r  0.29, P 	 0.05), prior birth-weight and percentile
pregnancies, these findings raised the question whether(r  0.44, P 	 0.005; r  0.59, P 	 0.0001) and
this adaptation, as seen in healthy women, would beprior gestational age at delivery (r  0.45, P 	 0.005).
preserved in the above-mentioned formerly preeclamp-Additionally, in THROMB, birth weight and percentile
inversely correlated with the seven-week circulating tic subgroups. To elucidate this pathogenetic problem,
-ANP (r  0.59, P 	 0.05; r  0.81, P 	 0.001, three consecutive hemodynamic and renal measure-
respectively). On the other hand, at this gestational age, ments were performed, once in the pre-pregnant state
the -ANP correlated positively with left atrial diameter and twice in early pregnancy, in women at risk for pre-
(r  0.51, P 	 0.0001), stroke volume (r  0.52, P 	 eclampsia on the basis of their medical history.
0.0001; Fig. 2C), CO (r 0.30, P	 0.05), and left ventric- The intergroup differences in demographic variables
ular work (r  0.32, P 	 0.05). were small and inconsistent. Most women in the THROMB
subgroup had thrombophilia in conjunction with the anti-
DISCUSSION phospholipid syndrome, protein-S-deficiency, or hyper-
homocysteinemia, an observation in line with previousIt is generally accepted that the clinical expression
of preeclampsia arises from endothelial dysfunction, a reports [1, 2]. An important finding was the lower plasma
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Fig. 2. (a) Linear regression analysis of plasma
volume (mL · kg1 lean body mass) as a func-
tion of-atrial natriuretic peptide (nmol · L1)
at seven weeks of gestation (y  0.11x 

74, P 	 0.001). (b) Linear regression analysis
of effective renal plasma flow (mL · min1 ·
1.73 m2) as a function of -atrial natriuretic
peptide (nmol · L1) at seven weeks of gesta-
tion (y  1.5x 
 903, P 	 0.001).
volume in the nonpregnant state in HYPERT and NON- inverse correlation between the achieved plasma volume
and the circulating level of -ANP. These data supportTHROMB subgroups as compared with controls. Never-
theless, at first sight, these differences did not seem to the concept that in these subgroups elevated -ANP
could have interfered with the initial plasma volumehave affected the early pregnancy adaptation, which also
have been reported by others [7, 15, 16]. Both controls expansion. The absence of an increase in -ANP in early
normal pregnancy has been observed previously [15]. Inand THROMB participants as well as HYPERT and
NONTHROMB subjects responded to pregnancy by a NONTHROMB, the rise in -ANP was paralleled not
only by a rise in left atrial diameter, but also by a lack ofrise in CO, renal hemodynamics, RAAS activity, and
plasma volume expansion, together with a fall in mean improvement in venous compliance. These phenomena
suggest that -ANP increases in response to a relativearterial blood pressure and TPVR. However, in HYP-
ERT and NONTHROMB, these changes were paral- venous overfill. In this reasoning, early pregnancy plasma-
volume expansion may be inhibited by a lack of concomi-leled by a rise in circulating levels of -ANP, a phenome-
non at seven weeks of pregnancy accompanied by an tant increase in venous storage capacity as a consequence
Spaanderman et al: Hemodynamic maladaptation to pregnancy 1405
Fig. 2 (Continued). (c) Linear regression anal-
ysis of stroke volume (mL) as a function of
-atrial natriuretic peptide (nmol · l1) at
seven weeks of gestation (y 0.11x
 70, P	
0.0001).
of either the absent rise in venous compliance or of an also to resetting and alteration of these blood pressure
regulating systems [6, 22–24]. The rise in baroreceptoradverse response of the autonomic control of the cardio-
activity, triggered by the afterload reduction, will raisevascular system. As a consequence, the rise in plasma
heart rate, cardiac contractility, and mobilization of ve-volume is inadequately accommodated in the venous
nous blood toward the arterial vascular compartment.system causing the venous pressure to increase and with
Meanwhile, the increased RAAS activity and nonosmoticit the -ANP release [17–19].
vasopressin release accelerate volume retention and res-It is known that in the early stages of essential hyper-
toration of the cardiac preload. A concomitant pregnancy-tension, plasma volume is reduced [20]. Plasma volume
related decrease in atrial responsiveness to stretch sup-was indeed reduced in the subjects in the HYPERT
presses the release of-ANP during the gradual restorationsubgroup, possibly as an early compensation to keep
of the central venous filling state in conjunction with thearterial blood pressure in the normal range in spite of
ongoing plasma volume expansion [17]. In HYPERT andthe presence of blood pressure-raising stimuli. It is un-
NONTHROMB subjects, the effects on these systemslikely that the lower plasma volume was secondary to
seems to be insufficient and paradoxical, as evidencedthe awareness of having hypertension, as the diagnosis
by the increase in -ANP, a decrease in norepinephrine“hypertension” was made in only 2 of the 10 women in
and a lower plasma volume at seven weeks as comparedthe HYPERT subgroup prior to the study [21]. Most data
with controls and THROMB. The latter two phenomenaon baseline hemodynamic and renal variables, plasma
might be explained as follows: A reduction in vascularvolume, and hormones in the NONTHROMB subgroup
resistance, compensated by elevation in stroke volume
were intermediate between HYPERT and controls. In
without elevation of arterial compliance, can be expected
addition, the NONTHROMB subjects resembled the to lower baroreceptor-mediated sympathetic tone when
HYPERT subjects with respect to the abnormal rise arterial filling is restored. In that case, to compensate
in circulating -ANP. The resemblance in laboratory for a reduction in afterload, the required higher cardiac
findings with the HYPERT subgroup led us to classify output can only be maintained at the expense of an ele-
these normotensive women as “latent” hypertensives [8]. vated stroke volume and atrial diameter, leading to the
On the basis of the results of the present study, we paradoxical enhanced release of -ANP and a reduced
postulate the following sequence of events in normal and release in norepinephrine. Even though pregnancy is
complicated pregnancy. The early pregnancy endocrine associated with an attenuated renal response to -ANP
environment triggers a generalized fall in systemic vascu- [22], its rise can be expected to alter volume regulation,
lar tone. This is accompanied by a higher vascular com- which is supported by the correlations between ANP
pliance [12]. As a consequence, the relative filling state and renal, cardiac, volume, and vascular adaptation. The
of the vascular bed decreases. The latter not only leads rise in venous compliance, as observed in HYPERT sub-
to an activation of cardiovascular regulatory systems jects, may be the result of the antihypertensive treatment
given after the nonpregnant measurement session.(baroreceptors, RAAS, venous stretch receptors), but
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